Editas Medicine, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the Annual Meeting of Stockholders held by Editas Medicine, Inc. on June 15, 2018. The filing details the outcomes of shareholder votes regarding director elections and the ratification of the independent auditor.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and does not contain financial performance data.
Material Changes
There are no material financial changes reported in this document. The primary events are the election of new directors and the ratification of the accounting firm.
Outlook, Risks, and Management Commentary
The filing contains no management commentary on future guidance, risks, contingencies, or unusual items. It strictly reports the voting results from the annual meeting.
Key Facts for Investors to Verify
- Director Elections: Andrew Hirsch and Boris Nikolic, M.D. were elected as Class II directors to serve until the 2021 Annual Meeting.
- Voting Results for Andrew Hirsch: 19,250,337 votes For; 5,554,038 votes Withheld; 13,855,407 Broker Non-Votes.
- Voting Results for Boris Nikolic, M.D.: 17,791,645 votes For; 7,012,730 votes Withheld; 13,855,407 Broker Non-Votes.
- Auditor Ratification: Stockholders ratified Ernst & Young LLP as the independent registered public accounting firm.
- Auditor Voting Results: 38,281,231 votes For; 239,137 votes Against; 139,414 votes Abstaining; 0 Broker Non-Votes.